Levitee Labs / Press Releases
Levitee Labs is on a mission to elevate the wellbeing of society
Learn more about how Levitee Labs is blending traditional health systems with the new frontier of value based health solutions, including psychedelic medicines and digitization, for better patient outcomes
12/01/22
Levitee Labs Signs Retail Distribution Agreement with Body Energy Club for MONKE Nutraceuticals
10/01/22
Levitee Labs Partners with Canntab Therapeutics to Provide Alternatives to Opioids
06/01/22
Levitee Labs Announces Medical Advisory Board
20/12/21
Levitee Labs Announces Strategic Partnership with LiveRx Research Group to Provide Equitable Access to Hepatitis C Care throughout Alberta, Canada
15/11/21
Levitee Labs Appoints Noha ElSayed as Executive Director for Levitee Clinics and Levitee Pharmacies in the Alberta Region
10/11/21
Levitee Labs Signs Letter of Intent to Acquire a Chain of Specialty Addiction Pharmacies Located in British Columbia
08/11/21
Levitee Labs Publishes First Combined Revenue Figures for September 2021 and October 2021
Levitee Labs Signs LOI to Acquire Controlling Interest in a R&D Compounding Pharmacy; Focus to be on Levitee-Branded Products
28/10/21
Levitee Clinics and Levitee Pharmacies Provide Insight on Integrated Acquisition Strategy for its Addiction and Pain Services
21/10/21
Levitee Labs Enters into Credit Facility For Up To $12 Million
18/10/21
Levitee Labs Announces Agreement with Adracare, a WELL Health Company, to Support Individuals with Addiction and Mental Health Conditions
14/10/21
Levitee Labs Appoints Dr. Mohammed Mosli as Chief People Officer of Levitee Clinics and Pharmacies in Alberta, Canada
12/10/21
Levitee Labs Signs Letter of Intent to Acquire Calgary Addiction and Compounding Pharmacy
05/10/21
Levitee Labs Publishes First Revenue Figures for August 2021
01/10/21
Levitee Labs Announces Listing On Frankfurt Stock Exchange
24/09/21
Levitee Labs Announces DTC Eligibility Approval
09/09/21
Levitee Labs Commences Trading in U.S. Under Ticker LVTTF
10/08/21
Levitee Labs Announces Azim Qazi as Head of Ecommerce and Consumer Packaged Goods
05/08/21
Levitee Labs Appoints NIH Physician-Scientist Dr. Fady Hannah-Shmouni as Chief Medical and Scientific Officer
04/08/21
Levitee Labs Completes Acquisition of Earth Circle Organics, Adds Superfoods Company to Portfolio
29/07/21
Levitee Labs Acquires Five Addiction Clinics in Alberta
Levitee Labs Acquires Three Specialized Alberta Pharmacies
28/07/21
Levitee Labs Announces Completion of Acquisition of BlockMD Telemedicine Platform
23/07/21
Levitee Labs Signs Definitive Agreements to Acquire Clinics, Pharmacies, and a Telemedicine Company in Alberta
22/07/21
Levitee Labs Provides Company Update Following CSE Listing
19/07/21
Levitee Labs to Commence Trading on the Canadian Securities Exchange Under the Ticker Symbol “LVT” on Wednesday, July 21st 2021
17/02/21
Levitee Labs Announces Closing of Oversubscribed Private Placement
Would you like to know more?
Receive email alerts
Email
Connect With Us: